Management of Gastroesophageal Junction Tumors

Surg Clin North Am. 2017 Apr;97(2):265-275. doi: 10.1016/j.suc.2016.11.004. Epub 2017 Feb 14.

Abstract

Gastroesophageal junction tumors have been increasing in incidence over time, with most tumors presenting at a locally advanced stage. The treatment plan depends on the stage at diagnosis. PET-CT and endoscopic ultrasound are used to determine clinical stage. Depending on the location of the tumor in the esophagus and stomach, treatment can include chemotherapy with or without radiation, followed by surgery if there is no disease progression. Prognosis is related to stage at diagnosis and response to preoperative treatment. Most surgery for gastroesophageal junction tumors can be performed minimally invasively, which helps decrease postoperative length of stay and morbidity from surgery.

Keywords: Adenocarcinoma; Barrett; Minimally invasive; Neoadjuvant.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery*
  • Deglutition Disorders / etiology
  • Esophageal Neoplasms / pathology
  • Esophageal Neoplasms / surgery*
  • Esophagogastric Junction / pathology
  • Esophagogastric Junction / surgery*
  • Humans
  • Neoplasm Staging
  • Postoperative Care / methods
  • Preoperative Care / methods
  • Risk Factors
  • Stomach Neoplasms / pathology
  • Stomach Neoplasms / surgery*
  • Treatment Outcome
  • Weight Loss